I would agree. Doesn't sound as if anything is imminent. More buying opps coming. You can also count on constant dilution of $10MM per quarter to keep the coffers full.
My sense is a partnership/collaboration for breast is closer than 6-12 months. Going back through the transcript notice how selective the team was when discussing breast study. The quote in the PR by Dr. Stopeck shed the most light.